Solo Pace, Inc.
Explore this company’s associated devices, FDA decisions and regulatory history.

Solo Pace, Inc.
- Regulatory records
- 1
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 1 FDA record to the applicant name Solo Pace, Inc.. The collection includes 1 510(k) clearance. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Jan 9, 2026 to Jan 9, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code DQX appears in 1 of the 1 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 1201 Sutter St., Suite 303, San Francisco, CA, 94109, US. Recorded on K252674, decision dated Jan 9, 2026.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Regulatory record history
Solo Pace Fusion System (SOLOFUSE1)
K252674 · 510(k) clearance
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.